期刊文献+

唐氏综合征产前筛查指标中位数倍数值在实验室质量控制中的应用价值探讨

Discussion on the application value of median multiple value of prenatal screening index for Down syndrome in laboratory quality control
下载PDF
导出
摘要 目的 探讨唐氏综合征产前筛查指标中位数倍数值(MoM)在实验室质量控制中的应用价值。方法 回顾性分析10 053例进行唐氏综合征产前筛查孕妇病例资料,均用化学发光法检测甲胎蛋白(AFP)、非结合雌三醇(uE3)、人绒毛膜促性腺激素(HCG),建立MoM监测系统,统计并分析唐氏综合征筛查结果及各指标MoM中位数(mMoM)值变动对筛查效率的影响。结果 筛查的10 053例孕妇中,共检出10例染色体异常者,检出率为0.10%,其中唐氏综合征的阳性率为4.25%,18-三体综合征的阳性率为2.21%,先天性神经管缺陷的阳性率为1.22%。AFP、游离人绒毛膜促性腺激素β亚基(F-β-HCG)、uE3各指标mMoM发生>10%的偏移会严重影响唐氏综合征筛查的质量。结论 唐氏综合征产前筛查指标的mMoM监测可提高检出水平,减少假阳性率,防止缺陷胚胎继续发育,保证优生优育,对提高我国人口素质具有重要意义。 Objective To investigate the application value of median multiple number(MoM) in prenatal screening for Down syndrome in laboratory quality control. Methods The data of 10 053 pregnant women who underwent prenatal screening for Down syndrome were retrospectively analyzed, and alpha-fetoprotein(AFP), unbound estriol(uE3) and human chorionic gonadotropin(HCG) were detected by chemiluminescence method, and a MoM monitoring system was established. The results of screening for Down syndrome and the effect of changes in the median MoM value of each index on screening efficiency were analyzed.Results Among the 10 053 pregnant women, 10 cases of chromosome abnormality were detected, the positive rate was 0.10%, the positive rate of Down syndrome was 4.25%, trisomy 18 syndrome was 2.21%, and the positive rate of congenital neural tube defect was 1.22%. If the mMoM of AFP, F-β-HCG and uE3were more than 10% offset, the screening quality of Down syndrome would be seriously affected. Conclusion The mMoM monitoring of prenatal screening index of Down syndrome can improve the detection level, reduce the false positive rate, prevent the development of defective embryos, ensure good birth and good birth, which is of great significance to improve the quality of Chinese population.
作者 何桂儿 曾小明 李丽清 黄霜 He Guier;Zeng Xiaoming;Li Liqing;Huang Shuang(Clinical Laboratory,Panyu Maternal and Child Health Hospital,Guangzhou 511483,China)
出处 《实用妇科内分泌电子杂志》 2022年第19期98-101,共4页 Electronic Journal of Practical Gynecological Endocrinology
关键词 唐氏综合征 产前筛查 中位数倍数值 实验室质量 Down syndrome Prenatal screening Median multiple value Laboratory quality
  • 相关文献

参考文献12

二级参考文献80

  • 1朱宝生,边旭明.“中孕期母血清学产前筛查技术标准”解读[J].中国产前诊断杂志(电子版),2012,4(4):1-5. 被引量:9
  • 2张斌,张月萍,张彬,李笑天.高龄孕妇唐氏综合征血清学筛查的价值[J].中国产前诊断杂志(电子版),2010,2(4):9-11. 被引量:7
  • 3夏燕萍,朱铭伟,李笑天,周和平,王静,吕菊香,Nanbert ZHONG.妊娠中期母血清唐氏综合征三联筛查4680例与不良妊娠结果分析(英文)[J].北京大学学报(医学版),2006,38(1):49-52. 被引量:6
  • 4王雅荪,罗军,王慧,徐慧君,沈歈忱,孟文珍,沈颖华,潘顺.孕中期11297例母血筛查胎儿唐氏综合征临床分析[J].中国优生与遗传杂志,2007,15(1):32-33. 被引量:27
  • 5Martinez JM,Borrell A,Antolin E,et al.Combining nuchal translucency with umbilical Doppler velocimetry for detecting fetal trisomies in the first trimester of pregnancy[J].Br J Obstet Gynaecol,1997,104(1):11-14.
  • 6Bindra B,Heath V,Nicolaicolaides KH.Screening for chromosomal defects by fetal nuchal translucency at 11 to 14 week[J].Clin Obstet Gynecol,2002,3(1):661-667.
  • 7Chasen ST,Mc Cullough LB,Chervenak FA,et al.Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?[J].Am J Obstet Gynecol,2004,190(3):769-774.
  • 8Adekunle O,Gopee A,EI-Sayed M,et al.Increased first trimester nuchal translucency:pregnancy and infant outcomes after routine screening for Down' s syndromein an unselected antenatal population[J].Br J Radiol,1999,72(857):457-460.
  • 9Bishop J,Dunstan FD,Nix BJ. The effects of gestation dating on the calculation of patient specific risks in Down's syndrome screening[J].Annals of Clinical Biochemistry,1995,(05):464-477.
  • 10Lambert-Messerlian GM,Eklund EE. Stability of first-and second-trimester serum markers after storage and shipment[J].Prenatal Diagnosis,2006,(01):17-21.

共引文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部